Latest
Hitting the books
As information drives capital with increasing speed through global markets, it's also remaking the investment landscape and, with...
Read more
Surprise,surprise
Seattle-based biotech PathoGenesis was riding high on tobramycin. Trade-named Tobi, it was a promising, easy-to-use new form of...
Read more
Behind the mask
Some of my most relaxing days at the office are the days when earnings are released. It's a blast – I come in and I talk to the...
Read more
Sector survey: Airlines
It is a lousy business,' says Kevin Murphy, senior airline analyst at Morgan Stanley Dean Witter, who has been covering this...
Read more
Walls come tumbling down
When a Wall Street analyst puts a buy recommendation on a company, he means 'it's okay to be in the passive, low-risk, low-payoff...
Read more